Cangene Corporation (TSX: CNJ) is a pharmaceutical company based in Winnipeg. Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. The company operates eight locations across North America and employs over 550 in Winnipeg.
Cangene is 61% owned by Canadian pharmaceutical giant Apotex and has many collaborative agreements with them. The company listed on the TSX.